MPM BioImpact’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
|
|||||
2023
Q1 | $5.06M | Hold |
|
|||||
2022
Q4 | $3.37M | Hold |
|
|||||
2022
Q3 | $6.07M | Hold |
|
|||||
2022
Q2 | $9.78M | Hold |
|
|||||
2022
Q1 | $9.3M | Hold |
|
|||||
2021
Q4 | $15.7M | Hold |
|
|||||
2021
Q3 | $28.7M | Hold |
|
|||||
2021
Q2 | $55.3M | Hold |
|
|||||
2021
Q1 | $74.4M | Hold |
|
|||||
2020
Q4 | $104M | Hold |
|
|||||
2020
Q3 | $68.5M | Hold |
|
|||||
2020
Q2 | $51.8M | Hold |
|
|||||
2020
Q1 | $26.1M | Hold |
|
|||||
2019
Q4 | $48.1M | Buy |
|